News – Portland Peptides (ARL)

AOD-9604 cartilage repair Aug 06, 2026 Retatrutide and AOD-9604 Stack to Preserve Cartilage During Weight LossSome compounds in this article are sold only as research chemicals and are not labelled for human consumption. Weight loss,...Read article

Cerebrolysin Aug 01, 2026 Cerebrolysin and NAD+ Stack for Post-Stroke RecoveryThe FDA panel's peptide vote could reshape access to Cerebrolysin and NAD+ stacks for post-stroke recovery. Explore the mechanistic synergy...Read article

FDA panel vote Jul 30, 2026 Retatrutide and Thymalin Stack for Immune Resilience During Rapid Weight Loss: What the FDA Panel Vote Means for AccessRapid weight loss from retatrutide stresses the immune system. Thymalin may restore T-cell function during catabolic states. An FDA panel...Read article

energy metabolism Jul 25, 2026 Retatrutide and NAD+ Stack to Counter GLP-1-Induced FatigueSome compounds in this article are sold only as research chemicals and are not labelled for human consumption. GLP-1 receptor...Read article

AMPK Jul 23, 2026 Retatrutide and MOTS-c Stack for Metabolic FlexibilityExploring how retatrutide's triple agonism and MOTS-c's mitochondrial signaling may synergize to enhance metabolic flexibility beyond weight lossRead article